PMID: 9160088May 1, 1997Paper

MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice

Scandinavian Journal of Immunology
A M EngelO Werdelin

Abstract

With the aim of studying possible T-cell mediated selection of the cells in growing tumours, 108 mice of the C.B-17 strain, either immunocompetent C.B-17 mice or histocompatible immunodeficient C.B-17 severe combined immune deficiency (scid) were treated with 3-methylcholanthrene (MCA) in two different dosages. A total of 51 tumours were obtained, 44 of which were established as uncloned tumour cell lines, and used for further study. Tumour incidence correlated with carcinogen-dosage in that more tumours developed in groups treated with a high MCA dose than in groups treated with a low MCA dose, but not with immune status of the tumour host. No significant difference in the level of MHC class I molecule expression was found between the two groups of tumours. The rate of rejection after transplantation to syngeneic immunocompetent hosts was significantly higher for the scid tumours than for the non-scid tumours. The authors suggest that this reflects an immunoselection performed by T cells in the immunocompetent host in which the tumour originated, which has eliminated highly immunogenic tumour cells, leaving non-immunogenic tumour cells to grow.

Citations

Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·A Garcia-LoraF Garrido
Mar 14, 2003·Current Opinion in Immunology·Thomas Blankenstein, Zhihai Qin
Jul 28, 2001·Trends in Immunology·M J Smyth, J A Trapani
Nov 30, 2006·Immunology and Cell Biology·A E Germenis, V Karanikas
Jun 5, 2002·The Journal of Experimental Medicine·Zhihai QinThomas Blankenstein
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Aug 29, 2012·Journal of Oncology·Valerie ChewJean-Pierre Abastado
May 4, 2007·The Journal of Clinical Investigation·Jeremy B Swann, Mark J Smyth
Aug 31, 2013·Molecular Cancer·Rudi BeyaertFilip De Keyser
Feb 7, 2006·Theoretical Biology & Medical Modelling·Richmond T Prehn
Nov 29, 2011·Aging Health·Anthony D FosterRonald E Gress
Mar 18, 2008·Cancer Immunology, Immunotherapy : CII·Karin E de Visser
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·C A ElmetsH Mukhtar
Jan 12, 2011·Annual Review of Immunology·Matthew D VeselyMark J Smyth
Sep 2, 2014·Applied Microbiology and Biotechnology·Cheng-Li WangChun-Jen Chen
Jan 3, 2012·Seminars in Cancer Biology·Melvyn T ChowMark J Smyth
Jan 4, 2012·Seminars in Cancer Biology·Boris EngelsHans Schreiber
Jul 31, 2007·Seminars in Cancer Biology·Thomas Blankenstein
Oct 9, 2004·Cancer Science·Hiroaki IkedaTakashi Nishimura
Jul 28, 2009·European Journal of Immunology·Thomas Kammertoens, Thomas Blankenstein
Oct 6, 2007·International Journal of Cancer. Journal International Du Cancer·Dafeng YangKebin Liu
Mar 28, 2007·Immunology·Ryungsa KimKazuaki Tanabe
Apr 12, 2011·The Journal of Pathology·Masoud H Manjili
Dec 2, 2000·Seminars in Cancer Biology·H SchreiberD A Rowley
May 10, 2012·The International Journal of Biochemistry & Cell Biology·Martin VillalbaNerea Allende-Vega
May 27, 2014·Frontiers in Immunology·Christian MaueröderChristian Berens
Jun 18, 2016·Journal of Immunology Research·John Reiser, Arnob Banerjee
Jul 30, 2009·British Journal of Cancer·T H Schreiber, E R Podack
Apr 22, 2003·Journal of Cellular Physiology·Angel Garcia-LoraFederico Garrido
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Angel Garcia-LoraFederico Garrido
Dec 31, 2003·Nature Immunology·Zhihai Qin, Thomas Blankenstein
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Sep 1, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Barry A KriegsmanKenneth L Rock
Apr 9, 2020·Frontiers in Immunology·Lara GibelliniAndrea Cossarizza
Dec 14, 2019·Cancer Immunology Research·Karin SchreiberMatthias Leisegang
Apr 24, 2018·Seminars in Cancer Biology·Chong T Luo, Ming O Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.